HIV treatment: latest news

HIV treatment resources

HIV treatment features

HIV treatment in your own words

HIV treatment news from aidsmap

More news

HIV treatment news selected from other sources

  • HIV resistance to favored treatment not uncommon

    Resistance to a key HIV drug is common worldwide and could mean trouble for treating and preventing the virus that causes AIDS, according to a new study.

    29 January 2016 | Reuters
  • Viread (Tenofovir, TDF) Linked With Liver Disease and Cancer

    Long-term use of Viread (tenofovir disoproxil fumarate, or TDF) is associated with an increased risk of end-stage liver disease (ESLD) as well as hepatocellular carcinoma (HCC, the most common form of liver cancer) among people with HIV.

    14 January 2016 | Poz
  • Undetectable & Low-level HIV Viral Replication

    Even people who are adherent to their medication regimens may experience occasional “blips” in their viral loads, experience viral rebound or maintain a steady, if low, viral load above undetectable levels. To understand why some people struggle to achieve or remain undetectable, we spoke with Keith Henry, MD, an HIV specialist at Hennepin County Medical Center who has more than 25 years of experience caring for people with HIV.

    06 January 2016 | BETA blog
  • NIH drops special 10% set-aside for AIDS research

    In a major shakeup for the HIV/AIDS research community, the National Institutes of Health (NIH) today announced it will no longer support setting aside a fixed 10% of its budget—or $3 billion this year—to fund research on the disease. The agency also plans to reprogram $65 million of its AIDS research grant funding this year to focus more sharply on ending the epidemic.

    15 December 2015 | Science
  • Top 10 HIV Clinical Developments of 2015

    What is most interesting about the past year's events is how our wonderful capacity for invention and innovation is matched by our incredible and frustrating ability to screw things up. So here are both the commendable and the concerning: my top 10 stories from 2015.

    08 December 2015 | The Body Pro
  • Can Charlie Sheen really have doctor-approved unprotected sex?

    Charlie Sheen did more than merely announce he’s HIV-positive on Tuesday morning’s “Today” show — he brought the disease and its myriad treatment methods straight to breakfast tables nationwide. In detailing his HIV journey, Sheen not only relieved himself of blackmail and innuendo — he introduced America to the impressive range of treatment options and procedures now available for the 37 million people living with HIV across the globe. Here’s what it all means for you.

    24 November 2015 | New York Post
  • 'The Fact That I Have HIV Is Not Because Of What I Did - It's Because Of What I Didn't Do'

    UK activist Angelina Namiba talks to Marie Claire about her HIV: "People still ask me ‘how I got’ HIV, almost assuming that I must have done something wrong. But HIV doesn’t discriminate, no matter whether you’re rich or poor, young or old, black or white, you name it. The fact that I have HIV is not because of what I did, it’s because of what I didn’t do. And what I didn’t do is what millions of young people are not doing in this world today – they’re not using a condom."

    19 November 2015 | Marie Claire
  • Sobering Results from Real World HIV Treatment Analysis

    The proportion of people with HIV whose treatment is successful appears lower in the real world than in clinical trials, a researcher said here.

    12 October 2015 | MedPage Today
  • Doctors Find Effective HIV Drug Course Free of Efavirenz

    Once considered part of the gold standard of HIV treatment, alternative regimens can now alleviate concerns about birth defects, psychiatric problems, and even suicide caused by the drug efavirenz. Research published this week shows that three alternative, first-line HIV treatments that do not include efavirenz are just as good at suppressing the virus and are better tolerated.

    08 October 2015 | Healthline
  • Tenofovir Alafenamide Combo Pill Matches Truvada for HIV Efficacy, but Easier on Bones and Kidneys

    A fixed-dose combination pill containing tenofovir alafenamide (TAF) worked as well in a Phase 3 trial as the current Truvada pill containing the older tenofovir disoproxil fumarate (TDF) -- which is used for both HIV treatment and pre-exposure prophylaxis or PrEP -- but causes less kidney and bone toxicity, according to an announcement this week from Gilead Sciences.

    04 September 2015 | HIVandHepatitis.com
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.